504 related articles for article (PubMed ID: 22241171)
1. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery of nanoparticles with CPPs.
Sawant R; Torchilin V
Methods Mol Biol; 2011; 683():431-51. PubMed ID: 21053148
[TBL] [Abstract][Full Text] [Related]
3. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
[TBL] [Abstract][Full Text] [Related]
4. Intracellular Delivery of Nanoparticles with Cell Penetrating Peptides.
Salzano G; Torchilin VP
Methods Mol Biol; 2015; 1324():357-68. PubMed ID: 26202282
[TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
6. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.
Zhou J; Zeng FQ; Li C; Tong QS; Gao X; Xie SS; Yu LZ
Chin Med J (Engl); 2005 Jan; 118(1):50-5. PubMed ID: 15642226
[TBL] [Abstract][Full Text] [Related]
7. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
8. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
[TBL] [Abstract][Full Text] [Related]
9. Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.
Chen J; Li S; Shen Q
Eur J Pharm Sci; 2012 Sep; 47(2):430-43. PubMed ID: 22796217
[TBL] [Abstract][Full Text] [Related]
10. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
[TBL] [Abstract][Full Text] [Related]
11. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides.
Dissanayake S; Denny WA; Gamage S; Sarojini V
J Control Release; 2017 Mar; 250():62-76. PubMed ID: 28167286
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles Modified with Cell-Penetrating Peptides: Conjugation Mechanisms, Physicochemical Properties, and Application in Cancer Diagnosis and Therapy.
Gessner I; Neundorf I
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32268473
[TBL] [Abstract][Full Text] [Related]
14. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
15. Intracellular transduction using cell-penetrating peptides.
Sawant R; Torchilin V
Mol Biosyst; 2010 Apr; 6(4):628-40. PubMed ID: 20237640
[TBL] [Abstract][Full Text] [Related]
16. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
Torchilin VP
Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
[TBL] [Abstract][Full Text] [Related]
17. CyLoP-1: a novel cysteine-rich cell-penetrating peptide for cytosolic delivery of cargoes.
Jha D; Mishra R; Gottschalk S; Wiesmüller KH; Ugurbil K; Maier ME; Engelmann J
Bioconjug Chem; 2011 Mar; 22(3):319-28. PubMed ID: 21319732
[TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetics of cell-penetrating peptides.
Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
[TBL] [Abstract][Full Text] [Related]
19. Classes and prediction of cell-penetrating peptides.
Lindgren M; Langel U
Methods Mol Biol; 2011; 683():3-19. PubMed ID: 21053118
[TBL] [Abstract][Full Text] [Related]
20. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]